Showing 101-110 of 350 grants

Title Institution Researcher Program Duration Total Award Amount
Role of ZBED3 in beta cell stress response and vulnerability against autoimmunity Trustees of Indiana University Erica Cai Cures 01-June-2026 to 29-February-2028 $383.433,16
Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes Trustees of Indiana University Jamie Felton Cures 01-February-2026 to 31-January-2029 $682.534,00
Design of Pump-Compatible Insulin-Glucagon Fusion Proteins Trustees of Indiana University Michael Weiss Improving Lives 01-April-2026 to 31-March-2027 $255.749,24
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900.000,00
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1.603.777,39
Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes Trustees of Columbia University in the City of New York Camillo Bechi Genzano Cures 01-March-2025 to 29-February-2028 $253.647,64
Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts Trustees of Columbia University in the City of New York Megan Sykes Cures 01-June-2024 to 31-May-2027 $791.063,66
Preclinical optimization of Treg therapy to reverse autoimmunity in T1D patient-derived immune systems Trustees of Columbia University in the City of New York Megan Sykes Cures 01-August-2026 to 31-July-2029 $1.189.893,00
Determining the role of SSTR2 on PRL-2903-mediated glucagon secretion Trustees of Columbia University in the City of New York Xiaojuan Chen Improving Lives 01-April-2026 to 31-March-2027 $199.999,39
Development of Low Cost, High Precision Nano Pumps for Insulin Delivery Torramics Inc. Sergey Gimelshein Improving Lives 01-March-2023 to 30-April-2027 $1.493.212,43